Form 483

CELLTRION Inc Form 483, 2024-05-03

FDA issued a Form 483 to CELLTRION Inc on 2024-05-03 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

CELLTRION Inc · Yeonsu District, Korea (the Republic of) · Issued May 3, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 May 2024
21 CFR 312.50

General responsibilities of sponsors

Cited by Scott N Lim

3 May 2024
21 CFR 600.80(b)

Review of Adverse Experiences - SOPs

Cited by Scott N Lim

3 May 2024
21 CFR 600.80(c)(1)(iii)

Reporting Requirements - submission of reports

Cited by Scott N Lim

Inspected site

CICELLTRION IncYeonsu District, Korea (the Republic of)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations1x
21 CFR 600.80(b)Cited across public-safe Form 483 observations1x
21 CFR 600.80(c)(1)(iii)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere